Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial

Objective: To compare the efficacy of tamsulosin, silodosin, and silodosin plus tadalafil as medical expulsive therapy (MET) for distal ureteric calculi. Methods: In all, 120 patients who met the inclusion criteria were randomised into one of three treatment arms: tamsulosin (Group A), silodosin (Gr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Md Jawaid Rahman, M. Shazib Faridi, Naloh Mibang, Rajendra Sinam Singh
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2018
Materias:
Acceso en línea:https://doaj.org/article/d41712547e6d4f768b12b2124a66cc1a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d41712547e6d4f768b12b2124a66cc1a
record_format dspace
spelling oai:doaj.org-article:d41712547e6d4f768b12b2124a66cc1a2021-12-02T10:12:19ZComparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial2090-598X10.1016/j.aju.2017.11.012https://doaj.org/article/d41712547e6d4f768b12b2124a66cc1a2018-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X17301468https://doaj.org/toc/2090-598XObjective: To compare the efficacy of tamsulosin, silodosin, and silodosin plus tadalafil as medical expulsive therapy (MET) for distal ureteric calculi. Methods: In all, 120 patients who met the inclusion criteria were randomised into one of three treatment arms: tamsulosin (Group A), silodosin (Group B), and silodosin plus tadalafil (Group C). The drugs were given for a maximum of 4 weeks. The primary endpoint was the stone expulsion rate and secondary endpoints were stone expulsion time, number of pain episodes, and side-effects associated with MET. The follow-up period was for 4 weeks, after which ureteroscopic lithotripsy was done to remove any stones that were not expelled. Results: There was a statistically significantly higher stone expulsion rate in Group C (90%) as compared to groups A (57.5%) and B (77.5%) with a shorter mean time to stone expulsion. Also, there were statistically fewer pain episodes in Group C as compared to groups A and B. There were no serious side-effects. Conclusion: The present study concludes that the combination of silodosin and tadalafil increases the ureteric stone expulsion rate and decreases the expulsion time significantly. This combination provided significantly better control of pain without any serious side-effects.Md Jawaid RahmanM. Shazib FaridiNaloh MibangRajendra Sinam SinghTaylor & Francis GrouparticleEfficacySilodosinTadalafilTamsulosinUreteric calculiDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss 2, Pp 245-249 (2018)
institution DOAJ
collection DOAJ
language EN
topic Efficacy
Silodosin
Tadalafil
Tamsulosin
Ureteric calculi
Diseases of the genitourinary system. Urology
RC870-923
spellingShingle Efficacy
Silodosin
Tadalafil
Tamsulosin
Ureteric calculi
Diseases of the genitourinary system. Urology
RC870-923
Md Jawaid Rahman
M. Shazib Faridi
Naloh Mibang
Rajendra Sinam Singh
Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
description Objective: To compare the efficacy of tamsulosin, silodosin, and silodosin plus tadalafil as medical expulsive therapy (MET) for distal ureteric calculi. Methods: In all, 120 patients who met the inclusion criteria were randomised into one of three treatment arms: tamsulosin (Group A), silodosin (Group B), and silodosin plus tadalafil (Group C). The drugs were given for a maximum of 4 weeks. The primary endpoint was the stone expulsion rate and secondary endpoints were stone expulsion time, number of pain episodes, and side-effects associated with MET. The follow-up period was for 4 weeks, after which ureteroscopic lithotripsy was done to remove any stones that were not expelled. Results: There was a statistically significantly higher stone expulsion rate in Group C (90%) as compared to groups A (57.5%) and B (77.5%) with a shorter mean time to stone expulsion. Also, there were statistically fewer pain episodes in Group C as compared to groups A and B. There were no serious side-effects. Conclusion: The present study concludes that the combination of silodosin and tadalafil increases the ureteric stone expulsion rate and decreases the expulsion time significantly. This combination provided significantly better control of pain without any serious side-effects.
format article
author Md Jawaid Rahman
M. Shazib Faridi
Naloh Mibang
Rajendra Sinam Singh
author_facet Md Jawaid Rahman
M. Shazib Faridi
Naloh Mibang
Rajendra Sinam Singh
author_sort Md Jawaid Rahman
title Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
title_short Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
title_full Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
title_fullStr Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
title_full_unstemmed Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: A randomised trial
title_sort comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomised trial
publisher Taylor & Francis Group
publishDate 2018
url https://doaj.org/article/d41712547e6d4f768b12b2124a66cc1a
work_keys_str_mv AT mdjawaidrahman comparingtamsulosinsilodosinversussilodosinplustadalafilasmedicalexpulsivetherapyforloweruretericstonesarandomisedtrial
AT mshazibfaridi comparingtamsulosinsilodosinversussilodosinplustadalafilasmedicalexpulsivetherapyforloweruretericstonesarandomisedtrial
AT nalohmibang comparingtamsulosinsilodosinversussilodosinplustadalafilasmedicalexpulsivetherapyforloweruretericstonesarandomisedtrial
AT rajendrasinamsingh comparingtamsulosinsilodosinversussilodosinplustadalafilasmedicalexpulsivetherapyforloweruretericstonesarandomisedtrial
_version_ 1718397537050689536